Skip to main content
Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
216.03
+14.07 (6.97%)
At close: Jun 26, 2026, 4:00 PM EDT
216.00
-0.03 (-0.01%)
After-hours: Jun 26, 2026, 7:44 PM EDT

Biogen Revenue by Segment
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Multiple Sclerosis
4.04B 4.04B 4.19B 4.18B 4.23B 4.35B 4.45B 4.55B
Multiple Sclerosis Growth
-4.34% -7.14% -5.76% -8.10% -8.37% -6.70% -6.60% -7.90%
Other
2.79B 2.77B 2.73B 2.74B 2.59B 2.46B 2.39B 2.42B
Other Growth
7.87% 12.53% 14.22% 13.22% 4.90% -4.87% -10.48% -2.92%
Rare Disease
2.15B 2.15B 2.17B 2.14B 2.13B 1.99B 1.87B 1.82B
Rare Disease Growth
0.98% 8.37% 16.58% 17.34% 23.36% 13.99% 4.21% 2.78%
Biosimilars
730.50M 729.10M 761.30M 761.10M 777.50M 793.60M 779.80M 777.50M
Biosimilars Growth
-6.05% -8.13% -2.37% -2.11% 0.39% 3.06% 3.07% 3.68%

Revenue by Geography
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
United States
3.63B 3.55B 3.46B 3.34B 3.25B 3.24B 3.25B 3.23B
United States Growth
11.97% 9.59% 6.39% 3.33% 1.85% 3.05% 3.53% 0.92%
International
3.51B 3.57B 3.82B 3.87B 3.98B 3.98B 3.96B 4.02B
International Growth
-11.83% -10.18% -3.44% -3.72% -0.65% -3.14% -5.18% -6.11%
Other
2.79B 2.77B 2.73B 2.74B 2.59B 2.46B 2.39B 2.42B
Other Growth
7.87% 12.53% 14.22% 13.22% 4.90% -4.87% -10.48% -2.92%
Other Geographic
- - 2.73B 2.74B 2.59B 2.46B 2.39B 2.42B 2.47B 2.59B
Other Geographic Growth
- - 14.22% 13.22% 4.90% -4.87% -10.48% -2.92% 1.98% 18.45%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.